Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 440 record(s)

Req # A-2023-000031

Adverse Drug Reactions (ADRs) for SOLIRIS. Report numbers: 001026765, E2B_06035783, E2B_06090605.

Organization: Health Canada

78 page(s)
July 2023

Req # A-2023-000041

Adverse Drug Reactions (ADRs). Report numbers: 001026369, E2B_06086821, E2B_06083913.

Organization: Health Canada

57 page(s)
July 2023

Req # A-2023-000044

Adverse Drug Reactions (ADRs). Report numbers: 000934571, E2B_03683830, 000936713, E2B_05008901, E2B_05011872, 000939394, 000940032, 000940033, 000941197, 000944869.

Organization: Health Canada

75 page(s)
July 2023

Req # A-2023-000045

Adverse Drug Reactions (ADRs). Report numbers: E2B_03729836, E2B_05115942.

Organization: Health Canada

25 page(s)
July 2023

Req # A-2023-000046

Adverse Drug Reactions (ADRs) for Alendronic Acid. Report numbers: E2B_02032723, E2B_02052527, 000720948, E2B_01976535, E2B_02188344, 000721045, E2B_01973094.

Organization: Health Canada

253 page(s)
July 2023

Req # A-2023-000084

Adverse Drug Reactions (ADRs). Report numbers: E2B_05621044, 001004597, E2B_05481749, E2B_05520035, E2B_05518699, E2B_05490881, E2B_05494291, 001005168, E2B_05445879.

Organization: Health Canada

132 page(s)
July 2023

Req # A-2023-000101

Adverse Drug Reactions (ADRs). Report numbers: E2B_05855808, E2B_05902199, E2B_05933136, E2B_05881017, E2B_05891201, E2B_05961937, E2B_05948318, E2B_05925325, E2B_05948173, E2B_05932868.

Organization: Health Canada

73 page(s)
July 2023

Req # A-2023-000102

Adverse Drug Reactions (ADRs). Report numbers: E2B_05931765, E2B_05932971, E2B_05948203, E2B_05948209, E2B_05948188, E2B_05928151, E2B_05922224, E2B_05917358, E2B_05927827, E2B_05944013.

Organization: Health Canada

66 page(s)
July 2023

Req # A-2023-000107

Adverse Drug Reactions (ADRs). Report numbers: E2B_04831230, E2B_04950010, E2B_03824918, E2B_05766145, E2B_01848863, E2B_04327424, E2B_05752679, 001017342, 001018593, 001018844.

Organization: Health Canada

459 page(s)
July 2023

Req # A-2023-000109

Adverse Drug Reactions (ADRs). Report numbers: 001016640, E2B_05891329, E2B_03021383, E2B_01668238, 000426346, E2B_04661733, E2B_04674007, E2B_00407289, E2B_05947180, E2B_02493086.

Organization: Health Canada

761 page(s)
July 2023
Date modified: